Monday, February 01, 2021 12:31:40 AM
I will correct you.
I hink some of those here have confused you.
MF never stated he would share data news at end of year.
That is over enthusiastic iHub boarders who are projecting their wishes upon other’s expectations.
He did state that they would hit initial data point by end of 2020.
In fact if you look at what MF says, he has been vague.
Why?
> they’re small, they have to play by the rules
> they are in constant contact with FDA,
> they’re protecting their patent application
But, you have to look beyond what Revive says.
He did acknowledge that 210 mark was enrolled by years end.
He just got more funding.
He hired a Thiol Donor Researcher.
Pharm-Olam has expanded sites.
The 1000 patient trial mark should be hit by February 1st, so I imagine data would come prior to the end of February. But we’ll see, because like everyone on here, it’s a best guess.
In fact right now, Only Pharm-Olam personnel probably know any results.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM